PT - JOURNAL ARTICLE AU - Rahele Kafieh AU - Roya Arian AU - Narges Saeedizadeh AU - Shervin Minaee AU - Zahra Amini AU - Sunil Kumar Yadav AU - Atefeh Vaezi AU - Nima Rezaei AU - Shaghayegh Haghjooy Javanmard TI - COVID-19 in Iran: A Deeper Look Into The Future AID - 10.1101/2020.04.24.20078477 DP - 2020 Jan 01 TA - medRxiv PG - 2020.04.24.20078477 4099 - http://medrxiv.org/content/early/2020/04/27/2020.04.24.20078477.short 4100 - http://medrxiv.org/content/early/2020/04/27/2020.04.24.20078477.full AB - The novel corona-virus (COVID-19) has led to a pandemic, affecting almost all countries and regions in a few weeks, and therefore a global plan is needed to overcome this battle. Iran has been among the first few countries that has been affected severely, after China, which forced the government to put some restriction and enforce social distancing in majority of the country. In less than 2 months, Iran has more than 80,000 confirmed cases, and more than 5,000 death. Based on the official statistics from Iran’s government, the number of daily cases has started to go down recently, but many people believe if the lockdown is lifted without proper social distancing enforcement, there is a possibility for a second wave of COVID-19 cases. In this work, we analyze at the data for the number cases in Iran in the past few weeks, and train a predictive model to estimate the possible future trends for the number of cases in Iran, depending on the government policy in the coming weeks and months. Our analysis may help political leaders and health officials to take proper action toward handling COVID-19 in the coming months.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was received.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThis study uses four data sources to predict COVID-19 disease, including COVID-19 data, basic information, detailed information for each country, as well as SARS Data. The COVID-19 Data (by John Hopkins university) contains daily number of confirmed/death/recovered people. The Basic information contains the information about date/country/province of the cases. The detailed information for each country (around 18576 observations) includes information such as Region/ Population/Area (sq. mi.)/ Pop. Density (per sq. mi.)/ Coastline(coast/area ratio)/ Net migration/ Infant mortality (per 1000 births)/GDP/Literacy (%)/ Phones (per 1000)/ Climate/ Birthrate/ Death-rate/ Agriculture/ Industry/ Service/Arable (%)/ Crops(%)/. The Occurrences of SARS Data (2539 observations) contains information on the number of confrmed/death/recovered people for SARS. https://coronavirus.jhu.edu/map.html https://data.humdata.org/dataset/novel-coronavirus-2019-ncov-cases